In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

Bed Bug Management, Prevention, and Research Act - Amends the Food, Agriculture, Conservation, and Trade Act of 1990 to direct the Secretary of Agriculture (USDA) to: (1) award grants for bed bug management and eradication, (2) appoint a bed bug task force, and (3) award grants for related research projects.

Amends the Federal Insecticide, Fungicide, and Rodenticide Act to include bed bugs in the definition of "vector."

Requires the submission and evaluation of efficacy data if a pesticide is labeled for or proposed to be labeled for the control of a public health pest. Prohibits the sale or distribution of any product that is marketed, distributed, or sold with a claim that such product will control a public health pest if the submitted data does not support such claim.

Directs the Administrator of the Environmental Protection Agency (EPA) to award grants through September 30, 2017, to three state agencies for a pilot program under which state subdivisions and housing authorities use such funds to supplement ongoing bed bug prevention and mitigation activities. (Requires at least one of the three grants to be awarded to a state agency that before November 1, 2009, submitted a public health exemption request which proposed a pesticide use to control bed bugs but which was voluntarily canceled.)
To amend the Food, Agriculture, Conservation, and Trade Act of 1990 and the Federal Insecticide, Fungicide, and Rodenticide Act to support efforts to control and eradicate bed bugs with respect to public health, and for other purposes.

Illegal Garnishment Prevention Act - Prohibits funds appropriated or otherwise made available to the Secretary of the Treasury, the Secretary of Veterans Affairs, or the Commissioner of Social Security for FY2010 or any fiscal year thereafter from being used to promote or otherwise encourage recipients of veterans benefits or benefits paid under title II (Old Age, Survivors and Disability Insurance) (OASDI) of the Social Security Act to use direct deposit for the payment of such benefits until: (1) the Secretary of the Treasury promulgates rules establishing procedures to ensure that such benefits are protected from attachment and garnishment; and (2) at least five of the seven members of the advisory committee established under this Act concur in advising the Secretary that such procedures provide adequate safeguards.

Establishes a Social Security Benefits Protection from Attachment or Garnishment Advisory Committee.
To prohibit the use of funds to promote the direct deposit of Veterans and Social Security benefits until adequate safeguards are established to prevent the attachment and garnishment of such benefits.

Drug Competition Act of 2002 - (Sec. 5) Requires a generic drug applicant that has submitted an Abbreviated New Drug Application (ANDA) and a brand name drug company that enter into an agreement, prior to the generic drug entering the market, regarding the manufacture, marketing, or sale of the brand name or the generic drug, or regarding the 180-day semi-exclusivity period referred to in the Federal Food, Drug, and Cosmetic Act as it applies to such ANDA or any other ANDA based on the same brand name drug, to each file such agreement and any related agreements with the Assistant Attorney General and the Federal Trade Commission (FTC). Makes an exception for agreements that solely concern purchase orders for raw material supplies, equipment and facility contracts, or employment or consulting contracts. Requires such agreements to be filed not later than ten business days after the date they are executed.(Sec. 7) Exempts any such information or documentary material filed from disclosure under the Freedom of Information Act. Prohibits such information or material from being made public, except as relevant to any administrative or judicial action or proceeding.(Sec. 8) Subjects an applicant or company to a civil penalty of up to $11,000 for each day such entity fails to comply with this Act, recoverable in a civil action brought by the United States or the FTC. Authorizes a U.S. district court to order compliance and grant equitable relief.
A bill to enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.